Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.27K Buy
2,013
+1,121
+126% +$3.88K ﹤0.01% 5152
2025
Q4
$3.04K Sell
892
-357
-29% -$1.73K ﹤0.01% 5376
2025
Q3
$8.48K Sell
1,249
-18,518
-94% -$153K ﹤0.01% 5078
2025
Q2
$269K Sell
19,767
-5,976
-23% -$56.4K ﹤0.01% 3925
2025
Q1
$140K Sell
25,743
-3,094
-11% -$17.6K ﹤0.01% 4397
2024
Q4
$143K Buy
28,837
+3,191
+12% +$16.7K ﹤0.01% 4635
2024
Q3
$134K Buy
25,646
+18,008
+236% +$104K ﹤0.01% 4619
2024
Q2
$52.4K Sell
7,638
-21,386
-74% -$196K ﹤0.01% 4552
2024
Q1
$298K Sell
29,024
-15,537
-35% -$115K ﹤0.01% 3839
2023
Q4
$369K Buy
44,561
+1,942
+5% +$14K ﹤0.01% 3605
2023
Q3
$266K Buy
+42,619
New +$185K ﹤0.01% 3491
2023
Q1
Sell
-1,130
Closed -$2.19K 5700
2022
Q4
$2.19K Buy
+1,130
New +$2.53K ﹤0.01% 5211
2021
Q3
Sell
-200
Closed -$2K 6072
2021
Q2
$2K Sell
200
-343
-63% -$3.95K ﹤0.01% 5980
2021
Q1
$9K Buy
+543
New +$9.78K ﹤0.01% 5698

Other funds holding LFMD

Citigroup's LFMD Position: Q1 2026 in Review

Citigroup increased its LifeMD (LFMD) stake by 126% in Q1 2026, buying an estimated $3.88K and bringing the position to 2,013 shares worth $7.27K. The position accounts for ﹤0.01% of the portfolio, ranked #5152.

Citigroup first reported a position in LFMD in Q1 2021 and has held it in 14 quarters since. The position peaked at $369K in Q4 2023. 102 funds tracked by Wall St. Rank hold LFMD as of Q1 2026.

  • Citigroup held 2,013 shares of LifeMD worth $7.27K as of Q1 2026.
  • Citigroup bought 1,121 LifeMD shares in Q1 2026, an estimated $3.88K.
  • LifeMD made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5152 holding.
  • Citigroup first reported a position in LifeMD in Q1 2021 and has held it in 14 quarters since.
  • Citigroup's LifeMD position peaked at $369K in Q4 2023.
  • 102 funds tracked by Wall St. Rank held LifeMD as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.